英语词典化工词典

1,2-Dimethyl hydrazine

1,2-Dimethyl hydrazine


  • 中文别名:1,2-二甲肼
  • 中文释义:1,2-二甲基肼;二甲基肼(对称);对称二甲基肼;1,2-二甲肼
  • 英文别名:1,2-dimethylhydrazine;
    Hydrazine,1,2-dimethyl;
    1,2-dimethyl hydrazine;
    Hydrazomethane;
    1,2-Dimethylhydrazin;
    sym-Dimethylhydrazine;
    Symmetrical-dimethylhydrazine;
    SDMH;
    N,N'-dimethyl-hydrazine 
  • CAS No.:540-73-8
  • 分子式:

    C2H8N2

  • 分子量:60.0992
  • 精确分子量:60.06870
  • PSA:24.06000
  • InChI:The Key: DIIIISSCIXVANO-UHFFFAOYSA-N
  • 分子结构式:

物化性质

外观与性状:
无色带氮气味的液体,有吸湿性的液体
密度:
0.759g/cm3
沸点:
81.5ºC at 760mmHg
存储条件/存储方法:
库房通风低温干燥,与酸,氧化剂分开储运存放
稳定性相关:

1.稳定性[16] 稳定

2.禁配物[17] 氧化剂、铜及其合金、铁、铁盐

3.避免接触的条件[18] 受热

4.聚合危害[19] 不聚合

其它信息:

1.性状:无色带氨气味的液体,有吸湿性的液体。[1]

2.熔点(℃):-9[2]

3.沸点(℃):81[3]

4.相对密度(水=1):0.83(20℃)[4]

5.饱和蒸气压(kPa):9.32(25℃)[5]

6.辛醇/水分配系数:-0.54(计算)[6]

7.闪点(℃):23(CC)[7]

8.溶解性:与水混溶,溶于乙醇、乙醚。[8]

安全信息

外观与性状:
无色带氮气味的液体,有吸湿性的液体
密度:
0.759g/cm3
沸点:
81.5ºC at 760mmHg
存储条件/存储方法:
库房通风低温干燥,与酸,氧化剂分开储运存放
稳定性相关:

1.稳定性[16] 稳定

2.禁配物[17] 氧化剂、铜及其合金、铁、铁盐

3.避免接触的条件[18] 受热

4.聚合危害[19] 不聚合

其它信息:

1.性状:无色带氨气味的液体,有吸湿性的液体。[1]

2.熔点(℃):-9[2]

3.沸点(℃):81[3]

4.相对密度(水=1):0.83(20℃)[4]

5.饱和蒸气压(kPa):9.32(25℃)[5]

6.辛醇/水分配系数:-0.54(计算)[6]

7.闪点(℃):23(CC)[7]

8.溶解性:与水混溶,溶于乙醇、乙醚。[8]

毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
MV2625000
CHEMICAL NAME :
Hydrazine, 1,2-dimethyl-
CAS REGISTRY NUMBER :
540-73-8
BEILSTEIN REFERENCE NO. :
1730826
LAST UPDATED :
199707
DATA ITEMS CITED :
88
MOLECULAR FORMULA :
C2-H8-N2
MOLECULAR WEIGHT :
60.12
WISWESSER LINE NOTATION :
1MM1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LCLo - Lowest published lethal concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
280 ppm/4H
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
163 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
220 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
176 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
36 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
35 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
24 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
29 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - hamster
DOSE/DURATION :
95 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
120 mg/kg/4W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Gastrointestinal - tumors Sense Organs and Special Senses (Eye) - effect, not otherwise specified
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
260 mg/kg/13W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Gastrointestinal - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
90 mg/kg/28W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Sense Organs and Special Senses (Eye) - effect, not otherwise specified Gastrointestinal - colon tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Parenteral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
160 mg/kg/16W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Gastrointestinal - colon tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
12500 ug/kg/24W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
25 mg/kg/24W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
200 mg/kg/10W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Lungs, Thorax, or Respiration - tumors Gastrointestinal - colon tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Rectal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
360 mg/kg/18W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Gastrointestinal - colon tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
400 mg/kg/2Y-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Gastrointestinal - colon tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
608 mg/kg/2Y-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Reproductive - Tumorigenic effects - uterine tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Implant
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
2 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Gastrointestinal - tumors Tumorigenic - tumors at site of application
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - hamster
DOSE/DURATION :
340 mg/kg/17W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Behavioral - ataxia Gastrointestinal - hypermotility, diarrhea
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
120 mg/kg/12W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Gastrointestinal - colon tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
20 mg/kg
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Gastrointestinal - tumors Gastrointestinal - colon tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
200 mg/kg/10W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Gastrointestinal - colon tumors Kidney, Ureter, Bladder - Kidney tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
300 mg/kg/20W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Gastrointestinal - colon tumors Reproductive - Tumorigenic effects - uterine tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
80 mg/kg/4W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Gastrointestinal - colon tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
300 mg/kg/11W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Gastrointestinal - colon tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
42 mg/kg/28W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors Gastrointestinal - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
420 mg/kg/28W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Gastrointestinal - tumors Kidney, Ureter, Bladder - Kidney tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
200 mg/kg/20W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Gastrointestinal - tumors Gastrointestinal - colon tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
400 mg/kg/10W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Gastrointestinal - colon tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
100 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
Morphological transformation
TYPE OF TEST :
Morphological transformation
TYPE OF TEST :
DNA damage
TYPE OF TEST :
DNA damage
TYPE OF TEST :
DNA damage
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
Morphological transformation
TYPE OF TEST :
DNA damage
TYPE OF TEST :
DNA damage
TYPE OF TEST :
DNA damage
TYPE OF TEST :
Unscheduled DNA synthesis
TYPE OF TEST :
Unscheduled DNA synthesis
TYPE OF TEST :
Mutation test systems - not otherwise specified
TYPE OF TEST :
DNA inhibition
TYPE OF TEST :
DNA inhibition
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Sister chromatid exchange
TYPE OF TEST :
Sister chromatid exchange

MUTATION DATA

TYPE OF TEST :
Mutation in mammalian somatic cells
TEST SYSTEM :
Rodent - hamster Lung
REFERENCE :
PAACA3 Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- Volume(issue)/page/year: 24,93,1983 *** REVIEWS *** IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 4,145,1974 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 4,145,1974 IARC Cancer Review:Group 2B IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 TOXICOLOGY REVIEW MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 39,111,1977 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-GERMANY;Skin;Carcinogen JAN 1993 OEL-SWEDEN:TWA 0.1 ppm (0.2 mg/m3);STEL 0.2 ppm (0.5 mg/m3);Skin;Carcinogen JAN 1993 OEL-SWITZERLAND:TWA 0.5 ppm (1.2 mg/m3);Skin;Carcinogen JAN 1993 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO HYDRAZINES-air:CA CL 0.03 ppm/120MREFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992
毒理学数据:

1.急性毒性[9]

LD50:100mg/kg(大鼠经口);36mg/kg(小鼠经口)

LC50:700~1000mg/m3(大鼠吸入,4h)

2.刺激性 暂无资料

3.致突变性[10] 微生物致突变:鼠伤寒沙门菌25μg/皿。DNA加合物:人肺1290μmol/L。程序外DNA合成:人肺100μl/L。

4.致癌性[11] IARC致癌性评论:G2A,人类可能致癌物。

5.其他[12] LCLo:280ppm(大鼠吸入,4h)

生态数据:

1.生态毒性 暂无资料

2.生物降解性[13]

好氧生物降解(h):168~672

厌氧生物降解(h):672~2688

3.非生物降解性[14] 空气中光氧化半衰期(h):0.5~5.2

4.其他有害作用[15] 该物质对环境有危害,对鱼类应给予特别注意。在环境中能被生物降解。

MSDS

国标编号: 32184
CAS: 540-73-8
中文名称: 1,2-二甲基肼
英文名称: Dimethyl hydrazine(symmetrical);1,2-Dimethyl hydrazine
别 名: 二甲基肼(对称)
分子式: C2H8N2;H3CNHNHCH3
分子量: 60.12
熔 点: -9℃ 沸点:81℃
密 度: 相对密度(水=1)0.83(2
蒸汽压: <23℃
溶解性: 与水混溶,溶于乙醇、醚
稳定性: 稳定
外观与性状: 无色带氮气味的液体,有吸湿性的液体
危险标记: 7(易燃液体)
用 途:

2.对环境的影响:
一、健康危害
侵入途径:吸入、食入、经皮吸收。
健康危害:误服、吸入蒸气或经皮肤吸收会中毒,并能灼伤皮肤。蒸气对粘膜有刺激作用。
二、毒理学资料及环境行为
急性毒性:LD50100mg/kg(大鼠经口)
致癌性:IARC致癌性评论:对人可能致癌。
危险特性:其蒸气与空气形成爆炸性混合物,遇明火、高热极易燃烧爆炸。与氧化剂能发生强烈反应,引起燃烧或爆炸。
燃烧(分解)产物:一氧化碳、二氧化碳、氧化氮。
3.现场应急监测方法:
 
4.实验室监测方法:
氨基亚铁氰化钠分光光度法(GB/T14376-93,水质)
气相色谱法;分光光度法《空气和废气监测分析方法》,国家环保局编
5.环境标准:
前苏联 车间空气中有害物质的最高容许浓度 0.1mg/m3
6.应急处理处置方法:
一、泄漏应急处理
疏散泄漏污染区人员至安全区,禁止无关人员进入污染区。应急处理人员戴自给式呼吸器,穿厂商特别推荐的化学防护服(完全隔离)。不要直接接触泄漏物。在确保安全情况下堵漏。用大量水冲洗,经稀释的洗液放入废水系统。如大量泄漏,利用围堤收容,然后收集、转移、回收或无害处理后废弃。
二、防护措施
呼吸系统防护:可能接触其蒸气时,应该佩戴防毒口罩。紧急事态抢救或撤离时,建议佩戴自给式呼吸器。
眼睛防护:戴化学安全防护眼镜。
身体防护:穿防腐工作服。
手防护:戴防化学品手套。
其它:工作现场严禁吸烟。工作后,淋浴更衣。实行就业前和定期的体检。保持良好的卫生习惯。
三、急救措施
皮肤接触:脱去污染的衣着,用肥皂水及清水彻底冲洗。若有灼伤,就医治疗。
眼睛接触:立即翻开上下眼睑,用流动清水冲洗15分钟。就医。
吸入:迅速脱离现场至空气新鲜处。呼吸困难时给输氧。呼吸停止时,立即进行人工呼吸。就医。
食入:误服者用水漱口,饮牛奶或蛋清,就医。
灭火方法:大火可用水,小火可用二氧化碳、干粉、砂土。

分子结构与计算化学数据

分子结构数据

1、摩尔折射率:18.5

2、摩尔体积(cm3/mol):79.1

3、等张比容(90.2K):167.6

4、表面张力(dyne/cm):20.0

5、介电常数:无可用的

6、极化率:7.33

7、单一同位素质量:60.068748 Da

8、标称质量:60 Da

9、平均质量:60.0983 Da

计算化学数据

1.疏水参数计算参考值(XlogP):-0.4

2.氢键供体数量:2

3.氢键受体数量:2

4.可旋转化学键数量:1

5.互变异构体数量:无

6.拓扑分子极性表面积24.1

7.重原子数量:4

8.表面电荷:0

9.复杂度:6

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

热门化工词典词汇